Unlocking the potential of TRPV1 based siRNA therapeutics for the treatment of chemotherapy-induced neuropathic pain
Authors:
- AkhileshAKAkhilesh
- Ankit UniyalAUAnkit Uniyal
- Vineeta TiwariVTVineeta Tiwari
- 1 January 2022
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 288, 120187
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation (CRG/2020/002621)
- Ministry of Human Resource Development (SPARC/2018-2019/P435/SL)
- Indian Council of Medical Research (5/3/8/17/ITR-F/2020, 5/3/8/44/ITR-F/2019-ITR)
This publication has 149 references indexed in Scilit:
- Neurogenic inflammation and the peripheral nervous system in host defense and immunopathologyNature Neuroscience, 2012
- The functions of TRPA1 and TRPV1: moving away from sensory nervesBritish Journal of Pharmacology, 2012
- Current progress of siRNA/shRNA therapeutics in clinical trialsBiotechnology Journal, 2011
- C. elegans TRP Family Protein TRP-4 Is a Pore-Forming Subunit of a Native Mechanotransduction ChannelNeuron, 2010
- Contribution of TRPV1-TRPA1 Interaction to the Single Channel Properties of the TRPA1 ChannelJournal of Biological Chemistry, 2010
- First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin DisorderMolecular Therapy, 2010
- Cellular and Molecular Mechanisms of PainCell, 2009
- Function and regulation of TRP family channels in C. elegansPflügers Archiv - European Journal of Physiology, 2009
- Roles of transient receptor potential channels in painBrain Research Reviews, 2009
- Selective Role for TRPV4 Ion Channels in Visceral Sensory PathwaysGastroenterology, 2008